Bausch+Lomb Results Presentation Deck

Integrated Platform Uniquely Positions Bausch+Lomb to Establish.... .LUMIFY® as a +$100M Brand BAUSCH+ LOMB LUMIFYⓇ BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.025% REDNESS RELIEVER EYE DROPS Works in 1 minute Lasts up to 8 hours Sterile BAUSCH + LOMB LUMIFY BAUSCH + LOMB BRIMONIDINE TARTRATE SOLUTION 0.05% REDNESS RELIEVER EYE DROPS Sterile #1 #1 97% in Redness Reliever category with -46% market share ¹ 1. IRI Panel Omnichannel; trademarks are property of respective owners. 2. IQVIA ProVoice Survey Data Ending Q3 2021 3. Data Source: Lieberman, Lumify Brand Health Monitor Study, October 2021. Physician- recommended product in the Redness Reliever category² Launched in U.S. and Canada; Expect to launch LUMIFY® in several international markets and grow franchise through line extensions Satisfaction rating in a recent brand tracking study with 243 participants³ 36% 31% 16% 11% 6% 0% 1Q18 % of Weekly Market Share in Redness Reliever Category¹ 3Q18 Lumify Visine 1Q19 3Q 19 1Q20 3Q20 Clear Eyes Rohto 1Q21 46% 25% 11% 8% Private Label All Other 7% 2% 3Q21 1Q22 15

View entire presentation